Loading company…
Shufang Pharmaceutical develops and commercializes medicines for rare diseases.
Shufang Pharmaceutical researches and commercializes rare disease medicines, including Anjali® (valmorolone oral suspension) for Duchenne muscular dystrophy and eriglitazone (MIN-102). The company also works in drug contract manufacturing, import and export, and wholesale. Founded in 2024, it is based in Yangzhou, China, and received venture funding from Lilly Asia Ventures, Prosperico Ventures, and Dingxin Venture Capital in June 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in